Unfortunately, I have to disagree with you 100% on $TMDX. I have been working in the transplantation field myself for years and the OCS is being phased out in more and more hospitals worldwide because the disposables, the perfusion solution and the system effectiveness are lagging far behind the competition. Furthermore, the OCS is too large, unwieldy, complicated, outdated and not as mobile as its competitors.
•
22
•
1Sem.
@Barsten So you wouldn't buy the share?
••